Navigation Links
USDM Life Sciences Announces New Solution for Continuous GxP Compliance on Microsoft
Date:7/22/2020

USDM Life Sciences, a premier consulting firm driving digital transformation and innovation in technology and compliance, announces a new solution to manage regulated workloads on Microsoft Azure.

Regulated biotechnology, pharmaceutical, and medical device companies must ensure every layer of their technology stack complies with FDA and global regulations. USDM's new managed service for regulated workloads in the public cloud covers end-to-end technology and compliance solutions to addresses business applications, cloud services, and global infrastructure. With Unify Public Cloud, Microsoft customers will get access to unmatched compliance services, fast-start accelerators, and defensible validation deliverables based on twenty years of regulatory domain expertise and technology solution implementation.

"Now, more than ever, life science companies are prioritizing their business transformation through cloud technologies to not only maintain business continuity but accelerate their high-impact growth outcomes," said Kevin Brown, CEO of USDM Life Sciences. "By providing a total, continuous, GxP compliant solution for regulated workloads, USDM can help minimize regulatory risk and maximize innovation for our customers creating vital drugs, therapies, and medical devices."

USDM's cost-effective, prepackaged, Unify Public Cloud solution speeds up the deployment and adoption of Azure, minimizes compliance risk, and realizes business value faster by leveraging decades of life sciences expertise.

"At Microsoft, we're focused on continually developing new ways to empower our customers to increase productivity and improve business outcomes," said Patty Obermaier, Vice President, U.S. Health & Life Sciences at Microsoft Corp. "USDM, delivers accelerated GxP solutions that enable continuous cloud compliance to help reduce regulatory burdens."

Unify Public Cloud for Azure addresses and meets a growing, critical demand for life science companies to enable complete digital business processes and efficiently manage GxP compliance requirements.

Learn More

Please join us for a webinar discussing how you can move your regulated GxP workload to Microsoft Azure.

Thursday, July 30th, 2:00 PM - 3:00 PM EDT

Register Here

Availability

Unify Public Cloud for Azure is available for all Microsoft life sciences customers on the Azure Marketplace. To learn how you can migrate your regulated workload to Azure, contact USDM at usdm@usdm.com.

About USDM Life Sciences

USDM Life Sciences provides strategy and compliant technology solutions to regulated life sciences companies and makes it easy to accelerate transformation and innovation. USDM Life Sciences focuses exclusively on the regulated biotechnology, pharmaceutical, and medical device industries and is a compliance partner with the world's top technology software developers. For more information, visit http://www.usdm.com.

Read the full story at https://www.prweb.com/releases/usdm_life_sciences_announces_new_solution_for_continuous_gxp_compliance_on_microsoft/prweb17267952.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. DuPont Nutrition & Biosciences Unveils Brewing Liquefaction Enzyme Solution AMYLEX® 6T
2. DuPont Nutrition & Biosciences Launches Bonlacta™ Dairy Enzyme in North America for Lactose-Free Market
3. Flagship Biosciences and Corritori Consulting Announce Strategic Alliance - Companies Now Delivering Regulatory Services to the Pharmaceutical Industry
4. Box, ComplianceQuest and USDM Life Sciences Partner to Launch Unify Compliance Cloud
5. Flagship Biosciences Hires New Vice President of Clinical Diagnostics
6. OU Health Sciences Center Partners With Pure MHC on COVID-19 Vaccine Project
7. Jason Burke Joins CREO, Inc. as Partner to Head Analytics and Data Sciences Practice
8. INDIGO Biosciences Announces Record Revenue Numbers for 2019
9. New Investments Boost Colorado’s Life Sciences Community
10. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
11. GIOSTAR Announces Medical Breakthrough in Biotechnology and Lifesciences To Manufacture Abundant, Safe Red Blood Cells From Stem Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2020)... ... , ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, ... list is the most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions ... reported three-year revenue growth of 71 percent. , The Inc. 5000 list represents ...
(Date:8/21/2020)... ... 2020 , ... NDA Partners Chairman Carl Peck, MD ... expertise in clinical trial planning and feasibility, regulatory inspection readiness, and clinical investigator ... career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, and anti-infective ...
(Date:8/5/2020)... ... August 05, 2020 , ... Regenative Labs has received approval from the Centers ... making them the first Wharton’s jelly allografts to be assigned a Q code and ... are the first Wharton’s jelly allograft product to be recognized as a 361 HCT/P ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... ... August 29, 2020 , ... DuPont Nutrition & ... Wuxi, China. The new plant operation will provide the local animal production industry ... , “This facility will improve the flexibility of our offerings to the Chinese ...
(Date:8/12/2020)... ... 2020 , ... The FSHD Society announced today that it ... Trial Research Network (FSHD CTRN), with consideration of follow-on funding of $300,000 ... research centers in the United States and Europe with expertise in FSHD clinical ...
(Date:8/7/2020)... ... 06, 2020 , ... VGXI, a highly regarded CDMO supporting ... purchase of greenfield for a new, expanded manufacturing facility. The site is located ... the initial acquisition, with an option to purchase an additional 21 acres for ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is now offering ... 50 million stem cells total, patients may choose which extremities they would like treated. ... joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is obtained from ...
Breaking Biology Technology: